全文获取类型
收费全文 | 1029篇 |
免费 | 208篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 51篇 |
妇产科学 | 11篇 |
基础医学 | 42篇 |
口腔科学 | 10篇 |
临床医学 | 209篇 |
内科学 | 253篇 |
皮肤病学 | 31篇 |
神经病学 | 60篇 |
特种医学 | 84篇 |
外科学 | 194篇 |
综合类 | 48篇 |
现状与发展 | 20篇 |
预防医学 | 69篇 |
眼科学 | 34篇 |
药学 | 35篇 |
中国医学 | 2篇 |
肿瘤学 | 84篇 |
出版年
2024年 | 7篇 |
2023年 | 42篇 |
2021年 | 24篇 |
2020年 | 26篇 |
2019年 | 12篇 |
2018年 | 53篇 |
2017年 | 51篇 |
2016年 | 45篇 |
2015年 | 43篇 |
2014年 | 45篇 |
2013年 | 71篇 |
2012年 | 28篇 |
2011年 | 37篇 |
2010年 | 51篇 |
2009年 | 73篇 |
2008年 | 36篇 |
2007年 | 29篇 |
2006年 | 33篇 |
2005年 | 20篇 |
2004年 | 24篇 |
2003年 | 17篇 |
2002年 | 18篇 |
2001年 | 23篇 |
2000年 | 21篇 |
1999年 | 21篇 |
1998年 | 28篇 |
1997年 | 32篇 |
1996年 | 43篇 |
1995年 | 29篇 |
1994年 | 19篇 |
1993年 | 22篇 |
1992年 | 11篇 |
1991年 | 8篇 |
1990年 | 13篇 |
1989年 | 12篇 |
1988年 | 16篇 |
1987年 | 17篇 |
1986年 | 13篇 |
1985年 | 15篇 |
1984年 | 8篇 |
1983年 | 8篇 |
1982年 | 10篇 |
1981年 | 6篇 |
1980年 | 5篇 |
1978年 | 15篇 |
1977年 | 9篇 |
1976年 | 8篇 |
1975年 | 7篇 |
1964年 | 5篇 |
1963年 | 4篇 |
排序方式: 共有1254条查询结果,搜索用时 15 毫秒
31.
32.
33.
Yang Zhu BM Xiaohong Liu MM Xin Wei MM Baisong Wang PhD Jiuchang Zhong MD Yi Fu MD 《Journal of clinical hypertension (Greenwich, Conn.)》2014,16(9):652-657
To study the relationship between nocturnal blood pressure (BP) variation and spontaneous intracerebral hemorrhage (ICH) among Chinese hypertensive patients and its clinical significance, the authors retrospectively screened 371 patients with primary hypertension (189 patients with ICH, 182 patients without ICH) in Shanghai and analyzed their demographics, clinical information, nocturnal blood pressure variability and medication. Compared with the control group, the levels of blood glucose, triglycerides, and creatinine were significantly increased in the ICH group, along with a marked reduction in nocturnal BP drop (P<.05). Multivariate logistic regression indicated that blood glucose, creatinine, and nocturnal mean arterial pressure were risk factors for ICH, and the magnitude of nocturnal BP drop was negatively related to the risk for ICH. There was no significant difference in the prevalence of reverse dippers between the large hematoma volume group and the small hematoma volume group (χ2=2.529, P=.112), nor among the patients taking angiotensin‐converting enzyme inhibitors, angiotensin receptor blockers, or calcium channel blockers (χ2=1.981, P=.371). Reverse dipping is associated with the risk for ICH, suggesting that appropriate antihypertensive drug and chronotherapy might be effective to normalize the rhythm of abnormal circadian variation in hypertensive patients. 相似文献
34.
Katharine J. Vearncombe Margaret Rolfe Brooke Andrew Nancy A. Pachana Margaret Wright Geoffrey Beadle 《The Clinical neuropsychologist》2013,27(8):1295-1313
This study examined whether chemotherapy-induced menopause affects cognitive functioning in women with early breast cancer. The neuropsychological performance of 121 breast cancer patients (age M?=?49.62, SD?=?8.11, range?=?25.25–67.92) treated with chemotherapy was assessed pre-chemotherapy, as well as 1, 6, and 18 months post-chemotherapy completion. Linear mixed modeling was used to evaluate the data. Type of menopause (pre, chemotherapy-induced, and post menopause) was found to significantly interact with cognitive performance on two cognitive variables. Specifically, chemotherapy-induced menopausal women did not show any significant changes in performance on an abstract reasoning task, while the pre-menopausal and post-menopausal groups significantly improved over time. A significant interaction on a test of finger dexterity and coordination was also found, although inspection of the results indicated that this was due to a significant improvement in the pre-menopausal groups at 6 months post chemotherapy. After chemotherapy most cognitive variables showed improvements over time, although two indicators of verbal memory showed significant declines immediately after chemotherapy, with improvement by 18 months post completion. The current study found little evidence to suggest that chemotherapy-induced menopause broadly affects cognitive functioning after treatment administration. However, longer follow-up assessments are warranted to assess the long-term effects of combined chemotherapy and endocrine treatment. 相似文献
35.
36.
David Adlam BA BM BCh DPhil Nicholas Evans MB BCh Aneil Malhotra MA MB BCh Disha Midha BCom/BSc BM Felicity Rowley BSc BM BCh David Hutchings MB ChB Mirae Shin BM BCh Guy Mole BSc Alexander Stockenhuber Mark Lumb BM BCh Jonathan Wordsworth MA MB BCh Sophie Frantal MSc J. Colin Forfar MD PhD FRCP 《Catheterization and cardiovascular interventions》2012,80(4):539-545
Objectives : To investigate rates of and reasons for second and subsequent stent procedures in an unselected, “real‐world” population. Background : Repeat stenting is the primary difference reported in clinical trials of alternative revascularization strategies. The incidence, indication, and outcome for repeat stenting in contemporary practice outside the more selective populations of trials and registries has not been described. Method : All patients undergoing a first percutaneous coronary intervention (PCI) procedure with stenting from January 2001 to August 2009 (10,509) from a large UK tertiary referral and district general hospital were identified. Mortality and the incidence, timing, and indication for repeat revascularization in this population were investigated from patient records. Results : Of 10,509 patients undergoing a first PCI and stent implant 23.5% underwent repeat angiography of which 11.2% required repeat PCI and 2% coronary artery bypass grafting (median follow‐up of 3.8 years). A total of 1.3% went on to a third PCI. The commonest indication for repeat stenting was disease progression remote from the original stent (46%) and planned staged PCI (23%); 21% had a stent‐related indication. Functional assessment before repeat stenting was used in one‐third of stable patients. Mortality was 2.5% per annum. Conclusions : In contemporary practice, patients undergoing a first stenting procedure have a low subsequent mortality, and the substantial majority (86.4%) requires no further revascularization over a median 3.8 year follow‐up. For those who do require repeat stenting, this is most commonly at a site remote from the first stent. © 2012 Wiley Periodicals, Inc. 相似文献
37.
38.
39.
40.